Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Devil's club root extract is a botanical preparation derived from the root and inner bark of *Oplopanax horridus*, a spiny shrub native to the Pacific Northwest of North America. Traditionally used by indigenous peoples, it is employed for its potential **antimicrobial, anti-inflammatory, adaptogenic, hypoglycemic, and immunomodulatory properties**[1][2][4][5][7][8]. Key phytochemicals include **polyynes** (such as falcarindiol and oplopandiol), phenylpropanoids, lignan glycosides, and various terpenoids[5][7]. It has demonstrated *in vitro* and animal model activity against bacteria, fungi, and mycobacteria (such as the tuberculosis pathogen), as well as anticancer, immunostimulatory, and blood sugar-lowering effects[3][5][7][8][9]. Most common traditional indications include arthritis, diabetes, tuberculosis, digestive and respiratory ailments, and skin conditions[1][2][3][4][6][8]. There are no clinical trials or approvals for pharmaceutical use; evidence remains largely preclinical or ethnobotanical.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on devil's club root extract.